Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report
Author(s) -
Gabriela Vilas Bôas Gomez,
Guillermo J. PonsEstel,
Gustavo Citera,
Emilie Soriano,
Verónica Saurit,
F. Benavidez,
E. Velozo,
David Dubinsky,
Ida Elena Exeni,
C. Gobi,
M. Díaz,
Amelia Granel,
A. Smichowsky,
Gonzalo Garate,
A. Quinteros,
E. Cavillon,
Ivan Petković,
M.S. Larroudé,
M. de la Sota,
A Cappuccio,
G. Berbotto,
Agustina Alvarez,
Sílvia Papasidero,
A.R. Domínguez Lázaro,
Mileydys Saborit García,
M. Sacnún,
S. Soares de Souza,
Alessandro Bertoli,
Victoria Bejarano,
Oscar Rillo,
E. Kerzberg,
R. Quintana,
SA Landeo Agüero,
L. Somma,
Vanesa Cruzat,
C. Battaglitti,
A. Perez Dávila,
M. Gallardo,
Daniela Figueiredo Corrêa Pereira,
M. Verando,
Sergio Paira,
L. Martínez,
N. Aste,
Cecilia Pisoni,
Erika Catay,
César Graf,
G. Casado,
María Celina de la Vega
Publication year - 2019
Publication title -
revista argentina de reumatología
Language(s) - English
Resource type - Journals
eISSN - 2362-3675
pISSN - 0327-4411
DOI - 10.47196/rar.v30i1.461
Subject(s) - medicine , cohort , adverse effect , emergency medicine , family medicine
Objective: update the results of the BIOBADASAR registry on safety, duration and causes of treatment interruption after 8 years of follow-up. Methods: BIOBADASAR is a safety record of biological therapies established by the Argentine Society of Rheumatology. The description of BIOBADASAR 3.0 is presented, a cohort of 53 centers in Argentina followed prospectively from August 2010 to January 2018.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom